扩大运动前亨廷顿病非运动症状与嗅觉的范围:一项初步研究

IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY
Neurodegenerative Diseases Pub Date : 2020-01-01 Epub Date: 2021-07-09 DOI:10.1159/000518136
Beatrice Heim, Dora Valent, Federico Carbone, Sabine Spielberger, Florian Krismer, Atbin Djamshidian-Tehrani, Klaus Seppi
{"title":"扩大运动前亨廷顿病非运动症状与嗅觉的范围:一项初步研究","authors":"Beatrice Heim,&nbsp;Dora Valent,&nbsp;Federico Carbone,&nbsp;Sabine Spielberger,&nbsp;Florian Krismer,&nbsp;Atbin Djamshidian-Tehrani,&nbsp;Klaus Seppi","doi":"10.1159/000518136","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The aim of this pilot study was to investigate change of olfactory functions in Huntington's disease (HD).</p><p><strong>Background: </strong>HD is a neurodegenerative disease characterized by motor, cognitive, and behavioral abnormalities. There are several studies reporting olfactory dysfunction in manifest and some studies in premanifest HD carriers, and a recent neuropathological study demonstrated HD-specific protein aggregation in the anterior olfactory nucleus in HD patients. In this study, we wanted to assess olfactory functions as a possible early nonmotor symptom of HD mutation carriers without disease-specific motor symptoms and HD patients.</p><p><strong>Methods: </strong>All participants had genetic confirmed HD and were prospectively recruited during their routine control in a specialized outpatient clinic of the Medical University of Innsbruck, Department of Neurology, Austria. Healthy controls (HCs) were caregivers from patients. They were only included if they were younger than 70 years, scored more than 24/30 points on the Mini Mental State Examination, and had no other disease compromising olfactory function. Furthermore, all participants were tested on the Sniffin' sticks 16-items identification test.</p><p><strong>Results: </strong>We included 23 patients with manifest HD, 13 HD mutation carriers, and 19 HCs. Mutation carriers showed significant impaired odor identification compared to HCs (p < 0.001), as well as Huntington's patients compared with both mutation carriers (p = 0.003) and HCs (p < 0.001).</p><p><strong>Conclusions: </strong>The results of this pilot study suggest that olfactory dysfunction may be an early nonmotor symptom of HD and could be a potential marker to assess disease progression.</p>","PeriodicalId":19115,"journal":{"name":"Neurodegenerative Diseases","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000518136","citationCount":"0","resultStr":"{\"title\":\"Extending the Spectrum of Nonmotor Symptoms with Olfaction in Premotor Huntington's Disease: A Pilot Study.\",\"authors\":\"Beatrice Heim,&nbsp;Dora Valent,&nbsp;Federico Carbone,&nbsp;Sabine Spielberger,&nbsp;Florian Krismer,&nbsp;Atbin Djamshidian-Tehrani,&nbsp;Klaus Seppi\",\"doi\":\"10.1159/000518136\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The aim of this pilot study was to investigate change of olfactory functions in Huntington's disease (HD).</p><p><strong>Background: </strong>HD is a neurodegenerative disease characterized by motor, cognitive, and behavioral abnormalities. There are several studies reporting olfactory dysfunction in manifest and some studies in premanifest HD carriers, and a recent neuropathological study demonstrated HD-specific protein aggregation in the anterior olfactory nucleus in HD patients. In this study, we wanted to assess olfactory functions as a possible early nonmotor symptom of HD mutation carriers without disease-specific motor symptoms and HD patients.</p><p><strong>Methods: </strong>All participants had genetic confirmed HD and were prospectively recruited during their routine control in a specialized outpatient clinic of the Medical University of Innsbruck, Department of Neurology, Austria. Healthy controls (HCs) were caregivers from patients. They were only included if they were younger than 70 years, scored more than 24/30 points on the Mini Mental State Examination, and had no other disease compromising olfactory function. Furthermore, all participants were tested on the Sniffin' sticks 16-items identification test.</p><p><strong>Results: </strong>We included 23 patients with manifest HD, 13 HD mutation carriers, and 19 HCs. Mutation carriers showed significant impaired odor identification compared to HCs (p < 0.001), as well as Huntington's patients compared with both mutation carriers (p = 0.003) and HCs (p < 0.001).</p><p><strong>Conclusions: </strong>The results of this pilot study suggest that olfactory dysfunction may be an early nonmotor symptom of HD and could be a potential marker to assess disease progression.</p>\",\"PeriodicalId\":19115,\"journal\":{\"name\":\"Neurodegenerative Diseases\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000518136\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurodegenerative Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000518136\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/7/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurodegenerative Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000518136","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/7/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:本初步研究的目的是探讨亨廷顿病(HD)嗅觉功能的变化。背景:HD是一种以运动、认知和行为异常为特征的神经退行性疾病。有几项研究报道了显性和预显性HD携带者的嗅觉功能障碍,最近的一项神经病理学研究表明HD患者的前嗅核中存在HD特异性蛋白聚集。在这项研究中,我们想评估嗅觉功能作为无疾病特异性运动症状的HD突变携带者和HD患者可能的早期非运动症状。方法:所有的参与者都有遗传病确诊,并在奥地利因斯布鲁克医科大学神经内科专科门诊的常规对照中前瞻性招募。健康对照(hc)是来自患者的护理人员。只有年龄小于70岁,在迷你精神状态检查中得分超过24/30分,并且没有其他影响嗅觉功能的疾病,他们才被纳入研究。此外,所有参与者都进行了嗅探棒16项识别测试。结果:我们纳入了23例显性HD患者,13例HD突变携带者和19例hcc患者。与hc相比,突变携带者的气味识别能力明显受损(p < 0.001),亨廷顿舞蹈症患者与突变携带者(p = 0.003)和hc相比(p < 0.001)。结论:这项初步研究的结果表明,嗅觉功能障碍可能是HD的早期非运动症状,可能是评估疾病进展的潜在标志。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Extending the Spectrum of Nonmotor Symptoms with Olfaction in Premotor Huntington's Disease: A Pilot Study.

Objective: The aim of this pilot study was to investigate change of olfactory functions in Huntington's disease (HD).

Background: HD is a neurodegenerative disease characterized by motor, cognitive, and behavioral abnormalities. There are several studies reporting olfactory dysfunction in manifest and some studies in premanifest HD carriers, and a recent neuropathological study demonstrated HD-specific protein aggregation in the anterior olfactory nucleus in HD patients. In this study, we wanted to assess olfactory functions as a possible early nonmotor symptom of HD mutation carriers without disease-specific motor symptoms and HD patients.

Methods: All participants had genetic confirmed HD and were prospectively recruited during their routine control in a specialized outpatient clinic of the Medical University of Innsbruck, Department of Neurology, Austria. Healthy controls (HCs) were caregivers from patients. They were only included if they were younger than 70 years, scored more than 24/30 points on the Mini Mental State Examination, and had no other disease compromising olfactory function. Furthermore, all participants were tested on the Sniffin' sticks 16-items identification test.

Results: We included 23 patients with manifest HD, 13 HD mutation carriers, and 19 HCs. Mutation carriers showed significant impaired odor identification compared to HCs (p < 0.001), as well as Huntington's patients compared with both mutation carriers (p = 0.003) and HCs (p < 0.001).

Conclusions: The results of this pilot study suggest that olfactory dysfunction may be an early nonmotor symptom of HD and could be a potential marker to assess disease progression.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neurodegenerative Diseases
Neurodegenerative Diseases 医学-临床神经学
CiteScore
5.90
自引率
0.00%
发文量
14
审稿时长
6-12 weeks
期刊介绍: ''Neurodegenerative Diseases'' is a bimonthly, multidisciplinary journal for the publication of advances in the understanding of neurodegenerative diseases, including Alzheimer''s disease, Parkinson''s disease, amyotrophic lateral sclerosis, Huntington''s disease and related neurological and psychiatric disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信